Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway 1Pulmonary and Critical Care Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China 2Department of Neonatology, Hangzhou Children’s Hospital, Hangzhou, China DOI 10.7717/peerj.17123 Academic Editor Vladimir Uversky Subject Areas Molecular Biology, Pharmacology Keywords Erythropoietin, Lung ischemia-reperfusion injury, FGF23 Copyright © Licence This is an open access article...